PrimeVigilance, an Ergomed company is pleased to announce and welcome the appointment of Dr. Olaolu Imasogie as Chief Medical Officer, with immediate effect.
Dr. Imasogie’s last position was Senior Vice President, Medical Affairs, Pharmacovigilance & Medical Information of Iroko Pharmaceuticals. Dr Imasogie joins us with more than 12 years of experience in Pharmacovigilance and Medical Information management and Senior leadership.
In addition, Dr Imasogie is qualified in clinical medicine, Microsoft Certified Systems engineering, continuous medical education, public health and pharmaceutical sales.
“I am very pleased that Dr. Imasogie has decided to join our company, bringing with him his unique expertise making him a valuable asset to the company growth ” commented Dr. Jan Petracek, CEO of PrimeVigilance.
If you would like to know more about our global drug safety services and how we can help, please contact us at email@example.com
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)